BMC Health Services Research (Apr 2024)

Exploring patients’ perspectives: a mixed methods study on Outpatient Parenteral Antimicrobial Therapy (OPAT) experiences

  • Sophie Peter,
  • Charlotte Oberröhrmann,
  • Holger Pfaff,
  • Clara Lehmann,
  • Kirsten Schmidt-Hellerau,
  • Vanessa Brandes,
  • Charlotte Leisse,
  • Christoph Heinrich Lindemann,
  • Peter Ihle,
  • Jutta Küpper-Nybelen,
  • Anna Hagemeier,
  • Nadine Scholten

DOI
https://doi.org/10.1186/s12913-024-11017-9
Journal volume & issue
Vol. 24, no. 1
pp. 1 – 11

Abstract

Read online

Abstract Background Outpatient Parenteral Antimicrobial Therapy (OPAT), an alternative to inpatient intravenous antibiotic therapy, has shown benefits in international studies such as increased patient satisfaction. Because OPAT has been used only sporadically in Germany so far, no structured results on patients’ experiences and concerns regarding OPAT have yet been available. This study therefore aims to explore the experiences of OPAT patients in a pilot region in Germany. Methods This is an observational study in a German pilot region, including a survey of 58 patients on their experiences with OPAT, and in-depth interviews with 12 patients (explanatory-sequential mixed-methods design). Results Patients reported that they were satisfied with OPAT. That a hospital discharge was possible and anti-infective therapy could be continued in the home environment was rated as being particularly positive. In the beginning, many patients in the interviews were unsure about being able to administer the antibiotic therapy at home on their own. However, healthcare providers (doctors and pharmacy service provider staff) were able to allay these concerns. Patients appreciated regular contact with care providers. There were suggestions for improvement, particularly concerning the organization of the weekly check-up appointments and the provision of information about OPAT. Conclusions Patients were generally satisfied with OPAT. However, the treatment structures in Germany still need to be expanded to ensure comprehensive and high-quality OPAT care. Trial registration NCT04002453, https://www.clinicaltrials.gov/ , (registration date: 2019–06-21).

Keywords